Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Company Profile and bullboard matches:

V.CMD
Sort by: Date|Relevance

The growing weaponization of space

In his recent State of the Union address, President Trump gave a shout-out to space exploration, highlighting the newly-created Space Force branch of the US Military, and NASA’s Artemis program of crewed lunar exploration. Artemis aims to put astronauts on ...

Investing in silver bullion coins

Silver is one of the most important and fascinating metals on the planet. The white metal’s bigger brother, gold, usually gets most of the attention. But there’s one thing no gold bull likes to talk about. It’s one of the sec...

Better & Cheaper than the Competition: A Deeper Look at a Revolutionary EV Charging Platform

(Image courtesy of IONiX Pro Battery Technologies Inc.) From new tech, apps, and delivering its products to customers, 2021 has been a busy year for Extreme Vehicle Battery Technologies Corp. ( CSE: ACDC , Forum ) and its new, cutting-edge battery storag...

Coverage Initiated on U.S.-Based Precision Therapy Developer

The key reasons this story is compelling are given in an H.C. Wainwright & Co. report. In an Oct. 3 research note, analyst Andrew Fein reported that H.C. Wainwright & Co. initiated coverage on Blueprint Medicines Corp. (BPMC:NASDAQ) with a Buy rating and a $100 per ...

Coronavirus China Infection Statistics Analysis, Probability Forecasts 1/2 Million Infected

We in the West are in still the CALM before the Coronavirus STORM stage, both in terms of infections and in terms of economic impact as we witness China's economy effectively grind to a halt, a harbinger of what to expect to come that the financial markets are STILL NOT disc...

Domo Posts 19% Growth in Q1 FY21 Revenue

Shares of cloud platform provider Domo Inc. traded 15% higher and set a new 52-week high price after the company reported Q1 FY21 financial results that included a 19% increase in y-o-y revenue. Cloud-based business platform company Domo Inc. (DOMO:NASDAQ) yester...

Blackrock Gold, Continental, Siemens: Spin-Off as driver of share price

In the case of growing and large companies, the decision may be made in the course of development that part of the operational business be formed into a separate entity. A so-called spin-off or spin-out can have various advantages. On the one hand, capital-intensive businesses...

Buzz on the Bullboards: Who's making the most of a bumpy summer?

The summer months of 2023 have been colourful among the Canadian and U.S. markets to say the least. This week, Wall Street was beat up after Moody’s cut the credit ratings of 10 regional U.S. banks and warned it could also downgrade some of the nation&Clos...

XPhyto: Proof of Concept for Mescalin Synthesis

It’s become a much talked-about story on both sides of the Atlantic. XPhyto Therapeutics Corp. ( CSE: XPHY ) (FSE: 4XT) (OTCQB: XPHYF) has earned considerable media coverage in recent months due to its expansion into the development of psychedelic d...

Where’s the "Big Money" headed now?

The remarkable week that just concluded actually began on February 12. Stocks plunged in the opening minutes of trading that morning as investors' faith in the global economic recovery was shaken. In China, policymakers again tightened monetary policy in a fight against rapi...
1 2